68Ga-NODAGA-RGD PET/ CT for Tumoral Neoangiogenesis

NCT02666547 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

42

Enrollment

OTHER

Sponsor class

Stopped lack of resources

Conditions

Pathological Angiogenesis

Interventions

DRUG: 68Ga-NODAGA-RGD PET/CT
RADIATION: 18F-FDG PET/CT
RADIATION: 18F-FET PET/CT

Sponsor

University of Lausanne Hospitals

Collaborators

[object Object]